FDA Drug Recalls

Recalls / Class III

Class IIID-0630-2017

Product

Nifedipine Extended-Release Tablets, 60 mg, 100-count bottles, Rx Only, Manufactured for Alvogen Inc. Pine Brook, NJ 07058 USA, NDC 47781-369-01.

Affected lot / code info
Lot #: BXH1P41, BXH1BEE1, BXH1BE2, BXH1BE1B, BXH1BE1A, BXH1P41A, Exp. 01/2018; BXH81R1, BXHBD41A, BXH5ZR1, BXH9AL1A, Exp. 06/2018; BXHCUD1A, BXHCUF2A, Exp. 01/2019.

Why it was recalled

Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib

Recalling firm

Firm
Alvogen, Inc
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
10 Bloomfield Ave Bldg B Ste 2, N/A, Pine Brook, New Jersey 07058-9743

Distribution

Quantity
N/A
Distribution pattern
Nationwide

Timeline

Recall initiated
2017-03-07
FDA classified
2017-04-04
Posted by FDA
2017-04-12
Terminated
2017-12-15
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0630-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: drug · FDA Drug Recalls